Abstract:Objective: Systemic sclerosis (SSc) is a chronic systemic disease characterized by immune dysregulation and fibrosis for which there is no effective treatment. Animal models are crucial for advancing SSc research. Tree shrews are genetically, anatomically, and immunologically closer to humans than rodents. Thus, the tree shrew model provides a unique opportunity for translational research in SSc. Methods: In this study, a SSc tree shrew model was constructed by subcutaneous injection of different doses of bleomycin (BLM) for 21 days. We assessed the degree of inflammation and fibrosis in the skin and internal organs, and antibodies in serum. Furthermore, RNA sequencing and a series of bioinformatics analyses were performed to analyze the transcriptome changes, hub genes and immune infiltration in the skin tissues of BLM induced SSc tree shrew models. Multiple sequence alignment was utilized to analyze the conservation of selected target genes across multiple species. Results: Subcutaneous injection of BLM successfully induced a SSc model in tree shrew. This model exhibited inflammation and fibrosis in skin and lung, and some developed esophageal fibrosis and secrum autoantibodies including antinuclear antibodies and anti-scleroderma-70 antibody. Using RNA sequencing, we compiled skin transcriptome profiles in SSc tree shrew models. 90 differentially expressed genes (DEGs) were identified, which were mainly enriched in the PPAR signaling pathway, tyrosine metabolic pathway, p53 signaling pathway, ECM receptor interaction and glutathione metabolism, all of which are closely associated with SSc. Immune infiltration analysis identified 20 different types of immune cells infiltrating the skin of the BLM-induced SSc tree shrew models and correlations between those immune cells. By constructing a protein-protein interaction (PPI) network, we identified 10 hub genes that were significantly highly expressed in the skin of the SSc models compared to controls. Furthermore, these genes were confirmed to be highly conserved in tree shrews, humans and mice. Conclusion: This study for the first time comfirmed that tree shrew model of SSc can be used as a novel and promising experimental animal model to study the pathogenesis and translational research in SSc.

Research update on animal model of Sjgren syndrome

Advances in the Pathogenesis and Treatment of Primary Sj(o)gren's Syndrome

Research Process of Animal Model of Gouty Arthritis

Animal Models in Systemic Sclerosis: an Update.

Advances in Pathogenesis of Sjögren’s Syndrome

Recent advances in pathogenesis research on Sjgren syndrome related dry eye

Pathogenesis and treatment of Sjogren's syndrome: Review and update

[Progress in Understanding the Pathogenesis of Sjögren's Syndrome in Non-Obese Diabetic Mice].

Update of research progress on the treatment for Sjgren's syndrome with traditional Chinese medicine and western medicine

A comprehensive review of Sjögren's syndrome: Classification criteria, risk factors, and signaling pathways

In perspective: Murine models of scleroderma

Transcriptomic and Single-Cell Analysis Reveals Regulatory Networks and Cellular Heterogeneity in Mouse Primary Sjögren’s Syndrome Salivary Glands

Challenges and opportunities in animal models of psoriatic arthritis

PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome

Research progress of relation between Sj(o)gren's syndrome and gut microbiota

Tree shrews as a new animal model for systemic sclerosis research

Advances in Relations between Sjgren's Syndrome and Viruses

Research progress of murine lupus nephritis models

Cell therapy in Sjögren's syndrome: opportunities and challenges

From Molecular Mechanism to the Etiology of Sjogren Syndrome

Progress in the field of animal models of antiphospholipid syndrome